DE3174241D1 - Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom - Google Patents
Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefromInfo
- Publication number
- DE3174241D1 DE3174241D1 DE8181303266T DE3174241T DE3174241D1 DE 3174241 D1 DE3174241 D1 DE 3174241D1 DE 8181303266 T DE8181303266 T DE 8181303266T DE 3174241 T DE3174241 T DE 3174241T DE 3174241 D1 DE3174241 D1 DE 3174241D1
- Authority
- DE
- Germany
- Prior art keywords
- manufacturing
- synthetic peptide
- antigenic
- peptide specific
- materials therefrom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000000890 antigenic effect Effects 0.000 title 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16975880A | 1980-07-17 | 1980-07-17 | |
US20243180A | 1980-10-30 | 1980-10-30 | |
US24805981A | 1981-03-27 | 1981-03-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3174241D1 true DE3174241D1 (en) | 1986-05-07 |
Family
ID=27389709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8181303266T Expired DE3174241D1 (en) | 1980-07-17 | 1981-07-16 | Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0044710B2 (de) |
KR (1) | KR870000702B1 (de) |
AU (1) | AU559234B2 (de) |
CA (1) | CA1194794A (de) |
DE (1) | DE3174241D1 (de) |
DK (1) | DK318481A (de) |
ES (1) | ES504033A0 (de) |
FI (1) | FI83662C (de) |
GR (1) | GR74319B (de) |
IE (1) | IE51410B1 (de) |
IL (1) | IL63224A (de) |
NO (1) | NO812341L (de) |
NZ (1) | NZ197734A (de) |
PH (5) | PH20629A (de) |
PT (1) | PT73346B (de) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5019383A (en) * | 1981-01-09 | 1991-05-28 | New York Blood Center, Inc. | Fatty acid carriers for synthetic peptides |
US4554101A (en) * | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
DE3109696A1 (de) * | 1981-03-13 | 1982-09-30 | Gerhard Dr. med. 7800 Freiburg Hunsmann | Verfahren zur herstellung eines als impfstoff geeigneten synthetischen peptids und es enthaltender impfstoff |
DE3112338C2 (de) * | 1981-03-28 | 1995-02-23 | Klaus Von Der Helm | Verwendung von Hybridisierungssonden zum Nachweis von HAV |
DE3275998D1 (en) * | 1981-12-22 | 1987-05-14 | Baylor College Medicine | Immunological composition and method for hepatitis b virus |
ZA831547B (en) * | 1982-03-15 | 1984-10-31 | New York Blood Center Inc | Fatty acid carriers for synthetic vaccines |
ZA831854B (en) * | 1982-03-26 | 1984-01-25 | Biogen Nv | Small peptides with the specificity of foot and mouth disease viral antigens |
DE3382459D1 (de) * | 1982-04-14 | 1991-12-19 | James L Bittle | Kuenstliches pikornavirusantigen. |
DE3228501A1 (de) * | 1982-07-30 | 1984-02-02 | Behringwerke Ag, 3550 Marburg | Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens |
ZA836080B (en) * | 1982-08-23 | 1984-04-25 | Scripps Clinic Res | Broad spectrum influenza antisera |
EP0105481A1 (de) * | 1982-09-30 | 1984-04-18 | The Wellcome Foundation Limited | Antigene und diese enthaltende Vakzine |
US4483793A (en) * | 1982-10-04 | 1984-11-20 | The Regents Of The University Of California | Dimeric oligopeptides as heptenic epitopic sites for hepatitis |
EP0107436A1 (de) * | 1982-10-11 | 1984-05-02 | The National Biological Standards Board | Polypeptiden zum Impfen gegen Enteroviren |
NZ207394A (en) * | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
US5242798A (en) * | 1983-07-21 | 1993-09-07 | Scripps Clinic And Research Foundation | Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same |
US5030565A (en) * | 1983-08-17 | 1991-07-09 | Scripps Clinic And Research Foundation | Polypeptide-induced monoclonal receptors to protein ligands |
US4615973A (en) * | 1983-09-30 | 1986-10-07 | The Rockefeller University | Genetically engineered organisms expressing surface proteins of T. cruzi |
DE3484244D1 (de) * | 1983-09-30 | 1991-04-11 | Massachusetts Inst Technology | Herstellung von cdna die hepatitis a virale sequenzen darstellen. |
US4777240A (en) * | 1984-03-08 | 1988-10-11 | Scripps Clinic And Research Foundation | SV40 expression vector containing HBxAg as an expression marker |
US4599230A (en) * | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
WO1985004103A1 (en) * | 1984-03-09 | 1985-09-26 | Scripps Clinic And Research Foundation | Synthetic hepatitis b virus vaccine including both t cell anc b cell determinants |
US4599231A (en) * | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
US4636463A (en) * | 1984-04-05 | 1987-01-13 | Scripps Clinic And Research Foundation | Antibodies to human interleukin-2 induced by synthetic polypeptides |
US4794168A (en) * | 1984-04-24 | 1988-12-27 | Scripps Clinic And Research Foundation | Leukemia-associated virus immunogen, vaccine and assay |
US4663436A (en) * | 1984-04-24 | 1987-05-05 | Scripps Clinic And Research Foundation | Leukemia-associated virus immunogen, vaccine and assay |
GB8432401D0 (en) * | 1984-12-21 | 1985-02-06 | Bennett C E | Liver fluke antigens |
GB8508685D0 (en) * | 1985-04-03 | 1985-05-09 | Minor P D | Peptides |
US4735896A (en) * | 1986-03-04 | 1988-04-05 | United Biomedical, Inc. | Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions |
JP2702911B2 (ja) * | 1985-09-11 | 1998-01-26 | ユナイテツド・バイオメデイカル・インコ−ポレ−テツド | 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法 |
US4772685A (en) * | 1985-10-02 | 1988-09-20 | Merck & Co., Inc. | Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies |
US4795740A (en) * | 1986-05-20 | 1989-01-03 | Cohen Eric A | Antiviral peptides and means for treating herpes infections |
US5066783A (en) * | 1986-05-20 | 1991-11-19 | Cohen Eric A | Antiviral peptides and means for treating herpes infections |
US4777239A (en) * | 1986-07-10 | 1988-10-11 | The Board Of Trustees Of The Leland Stanford Junior University | Diagnostic peptides of human papilloma virus |
DK354487A (da) * | 1986-07-11 | 1988-01-12 | Noboru Yanaihara | Oncogen-relaterede peptider |
EP0300213A1 (de) * | 1987-06-22 | 1989-01-25 | Hexal-Pharma Gentechnik GmbH & Co. KG | Virale, immunogen wirksame Peptidpartikel von Hepatitis A |
WO1989000166A2 (en) * | 1987-07-06 | 1989-01-12 | Peptide Technology Ltd | Growth hormone related peptide |
US5128319A (en) * | 1987-08-28 | 1992-07-07 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
US5055396A (en) * | 1987-11-03 | 1991-10-08 | Scripps Clinic And Research Foundation | Diagnostic methods and systems for quantifying apo ai |
AU3413989A (en) * | 1988-03-29 | 1989-10-16 | Scripps Clinic And Research Foundation | Diagnostic methods and systems for quantifying apo ai |
DE3911794A1 (de) * | 1989-04-11 | 1990-10-18 | Thomae Gmbh Dr K | Monoklonale antikoerper gegen rekombinaten humanen gewebeplasminogenaktivator mit definierter epitopspezifitaet, deren herstellung und deren verwendung |
CA2062975A1 (en) * | 1989-07-14 | 1991-01-15 | Gail F. Seelig | Antagonists of gm-csf derived from the carboxyl terminus |
EP0491077A1 (de) * | 1990-12-19 | 1992-06-24 | Medeva Holdings B.V. | Zusammensetzung verwendbar als therapeutisches Mittel gegen chronische virale Leberkrankheiten |
US7611713B2 (en) | 1993-03-05 | 2009-11-03 | Pharmexa Inc. | Inducing cellular immune responses to hepatitis B virus using peptide compositions |
US7252829B1 (en) | 1998-06-17 | 2007-08-07 | Idm Pharma, Inc. | HLA binding peptides and their uses |
US9340577B2 (en) | 1992-08-07 | 2016-05-17 | Epimmune Inc. | HLA binding motifs and peptides and their uses |
US5387504A (en) * | 1992-09-30 | 1995-02-07 | Merck & Co., Inc. | Monospecific antibodies and assay system for detecting stromelysin cleavage products |
WO1994008597A1 (en) * | 1992-10-14 | 1994-04-28 | The Scripps Research Institute | Methods for the detection of antigen-specific immune complexes |
ES2065254B1 (es) * | 1993-01-23 | 1995-07-16 | Inmunologia & Genetica Aplic | Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados. |
US6632613B1 (en) * | 1993-06-02 | 2003-10-14 | University Of Utah Research Foundation | Compositions and kits for fluorescence polarization assay of large molecules |
ATE256702T1 (de) * | 1993-12-09 | 2004-01-15 | Univ Utah Res Found | Zusammensetzungen und kits zur fluoreszenzpolarisierungsdosierung von grossen molekülen |
WO1998029442A1 (en) * | 1996-12-30 | 1998-07-09 | Innogenetics N.V. | ANNEXIN V-BINDING POLYPEPTIDES DERIVED FROM HBsAg AND THEIR USES |
CA2386341A1 (en) | 1999-11-18 | 2001-05-25 | Epimmune Inc. | Heteroclitic analogs and related methods |
US7026443B1 (en) | 1999-12-10 | 2006-04-11 | Epimmune Inc. | Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions |
US7462354B2 (en) | 1999-12-28 | 2008-12-09 | Pharmexa Inc. | Method and system for optimizing minigenes and peptides encoded thereby |
CA2818654A1 (en) * | 2000-10-20 | 2002-04-25 | Como Biotech Aps | Pregnancy-associated plasma protein-a2 (papp-a2) |
US7244580B2 (en) * | 2001-11-08 | 2007-07-17 | The Regents Of The University Of California | Epsilon immunoglobulin chain derived peptides for induction of anti-IgE antibodies |
SI2508596T1 (sl) | 2002-02-21 | 2016-01-29 | Institute Of Virology Slovak Academy Of Sciences | Monoklonska protitelesa, specifična za MN/CA IX, proizvedena iz MN/CA IX deficientnih miši, in postopki uporabe |
WO2008075788A1 (ja) * | 2006-12-20 | 2008-06-26 | Shino-Test Corporation | ヒトhmgb1と特異的に結合する鳥類由来の抗体、ヒトhmgb1の免疫学的測定方法及びヒトhmgb1の免疫学的測定試薬 |
US9969794B2 (en) | 2012-05-10 | 2018-05-15 | Visterra, Inc. | HA binding agents |
WO2017083627A1 (en) | 2015-11-13 | 2017-05-18 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
JP2022521819A (ja) | 2019-03-25 | 2022-04-12 | ビステラ, インコーポレイテッド | インフルエンザを処置および予防するための組成物および方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4237224A (en) * | 1974-11-04 | 1980-12-02 | Board Of Trustees Of The Leland Stanford Jr. University | Process for producing biologically functional molecular chimeras |
US4075194A (en) * | 1976-12-09 | 1978-02-21 | Yeda Research And Development Co., Ltd. | Novel synthetic undecapeptide and clinical assay |
GB2008123B (en) * | 1977-11-08 | 1982-09-08 | Genentech Inc | Method of means for microbial polypeptide expression |
US4193915A (en) * | 1978-04-13 | 1980-03-18 | Mckerns Kenneth W | Contraceptive, antibody generating, polypeptides |
NO794196L (no) * | 1978-12-22 | 1980-06-24 | Biogen Nv | Fremgangsmaate ved fremstilling av et rekombinert dna molekyl |
US4220565A (en) * | 1979-01-18 | 1980-09-02 | Scripps Clinic & Research Foundation | Immunochemical conjugates: method and composition |
SE447263B (sv) * | 1979-04-20 | 1986-11-03 | Bonnierfoeretagen Ab | Syntetisk, antigeniskt aktiv polypeptid och antigeniskt medel innehallande nemnda polypeptid |
IE52036B1 (en) * | 1979-05-24 | 1987-05-27 | Univ California | Non-passageable viruses |
-
1981
- 1981-07-02 IL IL63224A patent/IL63224A/xx unknown
- 1981-07-02 FI FI812092A patent/FI83662C/fi not_active IP Right Cessation
- 1981-07-06 PH PH25866A patent/PH20629A/en unknown
- 1981-07-09 NO NO812341A patent/NO812341L/no unknown
- 1981-07-10 PT PT73346A patent/PT73346B/pt unknown
- 1981-07-14 AU AU72836/81A patent/AU559234B2/en not_active Ceased
- 1981-07-15 IE IE1595/81A patent/IE51410B1/en unknown
- 1981-07-16 EP EP81303266A patent/EP0044710B2/de not_active Expired - Lifetime
- 1981-07-16 DK DK318481A patent/DK318481A/da not_active Application Discontinuation
- 1981-07-16 GR GR65525A patent/GR74319B/el unknown
- 1981-07-16 ES ES504033A patent/ES504033A0/es active Granted
- 1981-07-16 CA CA000381825A patent/CA1194794A/en not_active Expired
- 1981-07-16 KR KR1019810002588A patent/KR870000702B1/ko active
- 1981-07-16 NZ NZ197734A patent/NZ197734A/en unknown
- 1981-07-16 DE DE8181303266T patent/DE3174241D1/de not_active Expired
-
1983
- 1983-06-13 PH PH29042A patent/PH20597A/en unknown
- 1983-06-13 PH PH29044A patent/PH20133A/en unknown
- 1983-06-13 PH PH29043A patent/PH20598A/en unknown
- 1983-06-13 PH PH29041A patent/PH20603A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IE811595L (en) | 1982-01-17 |
AU559234B2 (en) | 1987-03-05 |
PH20133A (en) | 1986-10-02 |
GR74319B (de) | 1984-06-22 |
PH20597A (en) | 1987-02-24 |
PT73346A (en) | 1981-08-01 |
FI83662B (fi) | 1991-04-30 |
PH20629A (en) | 1987-03-06 |
CA1194794A (en) | 1985-10-08 |
EP0044710B2 (de) | 1991-02-06 |
KR830006423A (ko) | 1983-09-24 |
IL63224A0 (en) | 1981-10-30 |
PT73346B (en) | 1982-09-02 |
IE51410B1 (en) | 1986-12-24 |
PH20603A (en) | 1987-02-24 |
DK318481A (da) | 1982-01-18 |
PH20598A (en) | 1987-02-24 |
ES8305419A1 (es) | 1983-04-01 |
KR870000702B1 (ko) | 1987-04-07 |
ES504033A0 (es) | 1983-04-01 |
AU7283681A (en) | 1982-01-21 |
FI83662C (fi) | 1991-08-12 |
EP0044710A1 (de) | 1982-01-27 |
FI812092L (fi) | 1982-01-18 |
NZ197734A (en) | 1985-05-31 |
IL63224A (en) | 1985-05-31 |
EP0044710B1 (de) | 1986-04-02 |
NO812341L (no) | 1982-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3174241D1 (en) | Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom | |
US5080895B1 (en) | nd method of production and use thereof Specific antibody-containing substance from eggs a | |
GB2178041B (en) | Antigenic modification of peptides | |
JPS5579239A (en) | Innprocess material for making bottole of twooaxissextended synthetic resin and method of using said material | |
BG39638A3 (en) | Synthetic material based on silica and method for its preparation | |
EP0164583A3 (en) | Container made of synthetic resin and method for manufacture thereof | |
GB2121317B (en) | Laminar composite material and a method of its manufacture | |
GB2129411B (en) | Thermoelectric materials and method of making same | |
GB2074128B (en) | Mailing-containers and a method of manufacture thereof | |
EP0056249A3 (en) | Synthetic antigenic composition and process for making same | |
JPS557598A (en) | Silicon based synthetic substance and method | |
JPS54126111A (en) | Copying material and making method thereof | |
JPS54146950A (en) | Hottcathode material and method of fabricating same | |
JPS5579237A (en) | Bottle made of saturated polyester resin and method of manufacturing said bottle | |
GB2084158B (en) | Peptide and production thereof | |
ZA814637B (en) | Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom | |
JPS54127710A (en) | Pressureesensitive copying material and making method thereof | |
JPS5579236A (en) | Bottle made of twooaxissextended synthetic resin and method of manufacturing said bottle | |
GB2069018B (en) | Fabric and method of manufacture | |
JPS5579235A (en) | Bottle made of twooaxissextended synthetic resin and method of manufacturing said bottle | |
JPS54136983A (en) | Container made of synthetic resin and method of making said container | |
JPS56159683A (en) | Label and method of manufacturing label | |
JPS56113507A (en) | Vessel made of thin flexible synthetic material and its manufacturing method | |
JPS54143324A (en) | Copying material and making method thereof | |
DE3377400D1 (en) | Antigenic modification of polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8366 | Restricted maintained after opposition proceedings | ||
8339 | Ceased/non-payment of the annual fee |